High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice

Neurobiology of Disease

Volumn 45, Issue 1, 2012, Pages 529-538

  Bousquet, M ^a,b   St Amour, I ^a,b,c   Vandal, M ^b   Julien, P ^a   Cicchetti, F ^a,b   Calon, F ^a,b,d  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c HÉMA QUÉBEC   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

Cytokines; Dopamine; Dopaminergic neurons; Flow cytometry; Insulin resistance; Leukocytes; Nutrition; Obesity; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE TRANSPORTER; INTERLEUKIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; IMMUNE RESPONSE; INSULIN RESISTANCE; LEUKOCYTE MIGRATION; LIPID DIET; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; WEIGHT GAIN;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CHEMOKINE CCL2; CHEMOKINE CCL3; CORPUS STRIATUM; DIET, HIGH-FAT; DOPAMINE; DOPAMINERGIC NEURONS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-1ALPHA; MICE; NERVE DEGENERATION; SUBSTANTIA NIGRA;

EID: 82155166363     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.09.009     Document Type: Article

References (62)

1. Abbott R.D., Ross G.W., White L.R., Nelson J.S., Masaki K.H., Tanner C.M., Curb J.D., Blanchette P.L., Popper J.S., Petrovitch H. Midlife adiposity and the future risk of Parkinson's disease. Neurology 2002, 59:1051-1057.
2. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 2005, 11:973-984.
3. Bas J., Calopa M., Mestre M., Mollevi D.G., Cutillas B., Ambrosio S., Buendia E. Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism. J. Neuroimmunol. 2001, 113:146-152.
4. Bayer-Carter J.L., Green P.S., Montine T.J., VanFossen B., Baker L.D., Watson G.S., Bonner L.M., Callaghan M., Leverenz J.B., Walter B.K., Tsai E., Plymate S.R., Postupna N., Wilkinson C.W., Zhang J., Lampe J., Kahn S.E., Craft S. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch. Neurol. 2011, 68:743-752.
5. Bousquet M., Saint-Pierre M., Julien C., Salem N., Cicchetti F., Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 2008, 22:1213-1225.
6. Bousquet M., Gibrat C., Saint-Pierre M., Julien C., Calon F., Cicchetti F. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1401-1408.
7. Bousquet M., Gue K., Emond V., Julien P., Kang J.X., Cicchetti F., Calon F. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease. J. Lipid Res. 2011, 52(2):263-271.
8. Bruce-Keller A.J., White C.L., Gupta S., Knight A.G., Pistell P.J., Ingram D.K., Morrison C.D., Keller J.N. NOX activity in brain aging: exacerbation by high fat diet. Free Radic. Biol. Med. 2010, 49:22-30.
9. Calon F., Cicchetti F. Can we prevent Parkinson's disease with n-3 polyunsaturated fatty acids?. Futur. Lipidol. 2008, 3:133-137.
10. Calon F., Morissette M., Rajput A.H., Hornykiewicz O., Bedard P.J., Di Paolo T. Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications. Mov. Disord. 2003, 18:241-253.
11. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8:464-474.
12. Chen H., Zhang S.M., Hernan M.A., Willett W.C., Ascherio A. Weight loss in Parkinson's disease. Ann. Neurol. 2003, 53:676-679.
13. Chen H., Zhang S.M., Schwarzschild M.A., Hernan M.A., Willett W.C., Ascherio A. Obesity and the risk of Parkinson's disease. Am. J. Epidemiol. 2004, 159:547-555.
14. Chen H., O'Reilly E., McCullough M.L., Rodriguez C., Schwarzschild M.A., Calle E.E., Thun M.J., Ascherio A. Consumption of dairy products and risk of Parkinson's disease. Am. J. Epidemiol. 2007, 165:998-1006.
15. Cheung M.C., Spalding P.B., Gutierrez J.C., Balkan W., Namias N., Koniaris L.G., Zimmers T.A. Body surface area prediction in normal, hypermuscular, and obese mice. J. Surg. Res. 2009, 153:326-331.
16. Choi J.Y., Jang E.H., Park C.S., Kang J.H. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic. Biol. Med. 2005, 38:806-816.
17. Colditz G.A., Willett W.C., Rotnitzky A., Manson J.E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 1995, 122:481-486.
18. Costa J., Lunet N., Santos C., Santos J., Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J. Alzheimers Dis. 2010, 20(Suppl. 1):S221-S238.
19. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122(Pt 8):1437-1448.
20. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
21. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
22. Drouin-Ouellet, J., Gibrat, C., Bousquet, M., Calon, F., Kriz, J., Cicchetti, F., in press. The Role of the MYD88-dependent Pathway in MPTP-induced Brain Dopaminergic Degeneration. Journal of Neuroinflammation.
23. Etminan M., Gill S.S., Samii A. Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol. 2005, 4:362-365.
24. Felson D.T. Weight and osteoarthritis. Am. J. Clin. Nutr. 1996, 63:430S-432S.
25. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497-509.
26. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
27. Gao X., Chen H., Fung T.T., Logroscino G., Schwarzschild M.A., Hu F.B., Ascherio A. Prospective study of dietary pattern and risk of Parkinson disease. Am. J. Clin. Nutr. 2007, 86:1486-1494.
28. Gibrat C., Saint-Pierre M., Bousquet M., Levesque D., Rouillard C., Cicchetti F. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J. Neurochem. 2009, 109:1469-1482.
29. Gibrat C., Bousquet M., Saint-Pierre M., Levesque D., Calon F., Rouillard C., Cicchetti F. Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:193-203.
30. Glaser J.R., Glaser E.M. Stereology, morphometry, and mapping: the whole is greater than the sum of its parts. J. Chem. Neuroanat. 2000, 20:115-126.
31. Hiltunen M., Khandelwal V.K., Yaluri N., Tiilikainen T., Tusa M., Koivisto H., Krzisch M., Vepsalainen S., Makinen P., Kemppainen S., Miettinen P., Haapasalo A., Soininen H., Laakso M., Tanila H. Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J. Cell Mol. Med 2011, (Electronic publication ahead of print). 10.1111/j.1582-4934.2011.01384.x.
32. Hisanaga K., Asagi M., Itoyama Y., Iwasaki Y. Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease. Arch. Neurol. 2001, 58:1580-1583.
33. Hu G., Jousilahti P., Nissinen A., Antikainen R., Kivipelto M., Tuomilehto J. Body mass index and the risk of Parkinson disease. Neurology 2006, 67:1955-1959.
34. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., Hirsch E.C. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 1999, 19:3440-3447.
35. Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 1995, 4:257-269.
36. Julien C., Berthiaume L., Hadj-Tahar A., Rajput A.H., Bedard P.J., Di Paolo T., Julien P., Calon F. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem. Int. 2006, 48:404-414.
37. Julien C., Tremblay C., Phivilay A., Berthiaume L., Emond V., Julien P., Calon F. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging 2010, 31:1516-1531.
38. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., Czlonkowska A. The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 1999, 156:50-61.
39. Laflamme N., Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 1999, 73:309-321.
40. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
41. Logroscino G., Sesso H.D., Paffenbarger R.S., Lee I.M. Body mass index and risk of Parkinson's disease: a prospective cohort study. Am. J. Epidemiol. 2007, 166:1186-1190.
42. Lucas E.A., Li W., Peterson S.K., Brown A., Kuvibidila S., Perkins-Veazie P., Clarke S.L., Smith B.J. Mango modulates body fat and plasma glucose and lipids in mice fed a high-fat diet. Br. J. Nutr. 2011, 1-11.
43. Meissner W.G., Frasier M., Gasser T., Goetz C.G., Lozano A., Piccini P., Obeso J.A., Rascol O., Schapira A., Voon V., Weiner D.M., Tison F., Bezard E. Priorities in Parkinson's disease research. Nat. Rev. Drug Discov. 2011, 10:377-393.
44. Mody N., Agouni A., McIlroy G.D., Platt B., Delibegovic M. Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein. Diabetologia 2011, 54:2143-2151.
45. Morris J.K., Bomhoff G.L., Stanford J.A., Geiger P.C. Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1082-R1090.
46. Morrison C.D., Pistell P.J., Ingram D.K., Johnson W.D., Liu Y., Fernandez-Kim S.O., White C.L., Purpera M.N., Uranga R.M., Bruce-Keller A.J., Keller J.N. High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J. Neurochem. 2010, 114:1581-1589.
47. Nerurkar P.V., Johns L.M., Buesa L.M., Kipyakwai G., Volper E., Sato R., Shah P., Feher D., Williams P.G., Nerurkar V.R. Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation. J. Neuroinflammation. 2011, 8:64.
48. Nieman D.C., Henson D.A., Nehlsen-Cannarella S.L., Ekkens M., Utter A.C., Butterworth D.E., Fagoaga O.R. Influence of obesity on immune function. J. Am. Diet. Assoc. 1999, 99:294-299.
49. Park H.R., Park M., Choi J., Park K.Y., Chung H.Y., Lee J. A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci. Lett. 2010, 482:235-239.
50. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D., Checkoway H. Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat. Disord. 2009, 15:47-52.
51. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C., Arnold J.T., Rapoport S.I., Bazinet R.P. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry. 2007, 12:36-46.
52. Reale M., Iarlori C., Thomas A., Gambi D., Perfetti B., Di Nicola M., Onofrj M. Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun. 2009, 23:55-63.
53. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7265-7270.
54. Scaglione R., Di Chiara T., Cariello T., Licata G. Visceral obesity and metabolic syndrome: two faces of the same medal?. Intern. Emerg. Med. 2010, 5:111-119.
55. Strissel K.J., DeFuria J., Shaul M.E., Bennett G., Greenberg A.S., Obin M.S. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring). 2010, 18:1918-1925.
56. Teismann P., Tieu K., Choi D.K., Wu D.C., Naini A., Hunot S., Vila M., Jackson-Lewis V., Przedborski S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5473-5478.
57. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
58. Willett W.C., Manson J.E., Stampfer M.J., Colditz G.A., Rosner B., Speizer F.E., Hennekens C.H. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA. 1995, 273:461-465.
59. Willett W.C., Dietz W.H., Colditz G.A. Guidelines for healthy weight. N. Engl. J. Med. 1999, 341:427-434.
60. Winzell M.S., Coghlan M., Leighton B., Frangioudakis G., Smith D.M., Storlien L.H., Ahren B. Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice. Eur. J. Pharmacol. 2011, 663:80-86.
61. Wu H., Ghosh S., Perrard X.D., Feng L., Garcia G.E., Perrard J.L., Sweeney J.F., Peterson L.E., Chan L., Smith C.W., Ballantyne C.M. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007, 115:1029-1038.
62. Xu Q., Park Y., Huang X., Hollenbeck A., Blair A., Schatzkin A., Chen H. Diabetes and risk of Parkinson's disease. Diabetes Care 2011, 34:910-915.